NEWS & MEDIA
We’re not only at the front lines of therapeutic advancement, we’re also continuously making headlines in healthcare, business, and research markets.
PRESS RELEASES
BeyondSpring Reports Fourth-Quarter and Full-Year 2019 Financial Results and Operational Update
BeyondSpring Announces Data & Safety Monitoring Board Recommendation for Plinabulin to Continue NSCLC Phase 3 Dublin-3 Study Without Modification April 30, 2020 FDA Submission to Change the Primary Endpoint for Study 106 Phase 3 into an Industry First and Robust...
BeyondSpring Files 2019 Annual Report on Form 20-F
BeyondSpring Files 2019 Annual Report on Form 20-F April 30, 2020 NEW YORK, April 30, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a global biopharmaceutical company focused on the development of innovative cancer...
FDA Submission to Change the Primary Endpoint into an Industry First and Robust Clinical Measure for Superiority of CIN Phase 3 Study
FDA Submission to Change the Primary Endpoint into an Industry First and Robust Clinical Measure for Superiority of CIN Phase 3 Study April 29, 2020 The Potential for Superior and Rapid Onset Protection from Infection with Plinabulin-G-CSF Combination Marks First...
FDA Submission to Change the Primary Endpoint into an Industry First and Robust Clinical Measure for Superiority of CIN Phase 3 Study
FDA Submission to Change the Primary Endpoint into an Industry First and Robust Clinical Measure for Superiority of CIN Phase 3 Study April 29, 2020 The Potential for Superior and Rapid Onset Protection from Infection with Plinabulin-G-CSF Combination Marks First...
BeyondSpring to Host Fourth-Quarter and Full-Year 2019 Financial Results and Operational Update Conference Call on April 30, 2020
BeyondSpring to Host Fourth-Quarter and Full-Year 2019 Financial Results and Operational Update Conference Call on April 30, 2020 April 23,, 2020 NEW YORK, April 23, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global...
MEDIA
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.